Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Fetal Neonatal Med. 2005 Jun;10(3):209-20. Epub 2005 Mar 25.

Stem cell medicine: umbilical cord blood and its stem cell potential.

Author information

1
National Blood Service, Oxford and Colindale, UK; Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK. suzanne.watt@nbs.nhs.uk

Abstract

The ultimate aim of stem cell research is to improve patient outcomes and quality of life, and/or to effect a cure for a variety of inherited or acquired diseases. Improved treatments rely on developments in stem cell therapies and the discovery of new therapeutic drugs that regulate stem cell functions. These complement each other for the repair, regeneration and replacement of damaged or defective tissues. Stem cells may be sourced or derived from blood and tissues postnatally ('adult' stem cells), from the fetus (fetal stem cells) or from the blastocyst in the developing embryo prior to implantation (embryonic stem cells), each forming a unique component of the revolution in stem cell research and therapies. This review will concentrate on recent developments in the use of haemopoietic stem cells from umbilical cord blood for the transplantation of patients with haematological disorders. It will conclude with a summary of the potential of other umbilical cord blood-derived stem cells for tissue repair or regeneration.

PMID:
15927877
DOI:
10.1016/j.siny.2005.02.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center